Medtech M&A: The industry’s biggest mergers and acquisitions of 2021

[Image from Jp Valery on Unsplash]

Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more.

Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired.

Here are the 10 biggest mergers and acquisitions in medtech in 2021:


Read more
  • 0

Boston Scientific completes Preventice buy, divests BTG Pharmaceutical business

Boston Scientific (NYSE:BSX) announced that it completed its acquisition of Preventice Solutions that could be worth up to $1.225 billion.

The transaction includes a cash payment of $925 million upfront with up to an additional $300 million in potential commercial milestone payments available. Accounting for the company’s approximately 22% equity stake in Preventice prior to the acquisition, the deal will be worth approximately $720 million upfront and $230 million in potential milestone payments, according to a news release.

Marlborough, Mass.-based Boston Scientific announced the planned acquisition of Minneapolis-based Preventice on Jan. 21, 2020.

Preventice designs mobile health solutions and remote monitoring offerings for patients with cardiac arrhythmias. Among its products are wearables, including the PatientCare platform and BodyGuardian family of monitors.

BodyGuardian monitors use a fully-integrated, cloud-based platform for clini…

Read more
  • 0

Medical Alley startups raise $1.4B

The Medical Alley Association announced that its startups recorded a record-setting year with $1.4 billion in fundraising in 2020.

Having broken the $1 billion barrier in 2019, the region topped that mark by the third quarter, raising nearly another half-million by the end of the year, according to a news release.

Bright Health and Bind Benefits, two health plan startups, along with Minneapolis-based Preventice Solutions — a developer of mobile health solutions and remote monitoring service for cardiac arrhythmias which was recently acquired by Boston Scientific — led the way in funding.

Preventice’s $137 million raised in 2020 topped medical device companies belonging to the region, while Bright raised a $500 million Series E to lead all Medical Alley companies.

Medical Alley’s device industry in total raised over $507 million. Relievant Medsystems followed Preventice at $70 million raised, while CVRx Inc. at $50 million and HistoSoni…

Read more
  • 0

MedTech 100 roundup: Another peak for the industry

Medtech has been on the rise in 2021 and the past week saw that trend continue, as the industry hit yet another all-time best mark.

MassDevice‘s MedTech 100 index reached 107.4 points on Jan. 20, topping the all-time best of 106.81 points set on Jan. 8. That mark represents a 16% jump from the pre-pandemic high of 92.32 set on Feb. 19, 2020, and a 72.9% overall leap from the lowest point of 62.13 set on March 23, 2020.

Here are some of the best-performing medtech stocks from 2020.

The high point could not be sustained, but the industry stayed strong, finishing at 106.4 to end the week on Jan. 22. Medtech’s finish to last week was enough to top the previous seven days, coming in 0.6% ahead of the 105.8-point mark set on Jan. 15.

While medtech saw slight growth from the previous week, one of the overall markets saw a larger jump, with the S&P 500 Index rising 1.9%. The Dow Jones Industrial Average fared identically to medtech, rising 0.6%.

Read more
  • 0

Boston Scientific to acquire Preventice Solutions

Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire Preventice Solutions.

Minneapolis-based Preventice designs mobile health solutions and remote monitoring services for patients with cardiac arrhythmias. Its wearables include the PatientCare platform and BodyGuardian family of monitors.

Preventice’s BodyGuardian monitors use a fully-integrated, cloud-based platform for clinical technicians and AI algorithms to provide insights leading to improved clinical diagnoses and outcomes. The company’s BodyGuardian Mini Plus, the newest system in its portfolio, features multiple electrode options to enhance rhythm detection while it is also waterproof, repositionable and can be used in all modalities of short-term and long-term monitoring.

Marlborough, Mass.-based Boston Scientific’s acquisition of the company includes an upfront cash payment of $925 million with an additional $300 million availabl…

Read more
  • 0